Day

Forbes: India's War On Intellectual Property Rights May Bring With It A Body Count September 16, 2013 By: Sally Pipes Last month, drug maker Roche withdrew its patents for the breast-cancer drug Herceptin in India — and thus gave tacit approval to other companies to make low-cost generic versions of the drug. But the withdrawal of ...